Compare BGS & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BGS | BCYC |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United Kingdom |
| Employees | 86 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.5M | 360.7M |
| IPO Year | 2004 | 2019 |
| Metric | BGS | BCYC |
|---|---|---|
| Price | $5.56 | $5.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $4.70 | ★ $13.90 |
| AVG Volume (30 Days) | ★ 1.9M | 593.0K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 13.64% | N/A |
| EPS Growth | ★ 83.02 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,828,687,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.82 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.67 | $4.24 |
| 52 Week High | $7.24 | $9.55 |
| Indicator | BGS | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 63.75 | 53.49 |
| Support Level | $4.85 | $5.03 |
| Resistance Level | $6.38 | $5.90 |
| Average True Range (ATR) | 0.21 | 0.26 |
| MACD | 0.06 | 0.09 |
| Stochastic Oscillator | 95.35 | 75.68 |
B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.